Skip to main content
Caplight Logo









AccuLine

AccuLine

Private
IsraelHealthcare & Life Scienceshttps://acculine-medical.com/

Last Round

Seed

Jul 14, 2024

Total Funding Raised

$5.5M

Company Overview

AccuLine is a medical equipment manufacturing company that is developing CORA, an accurate, non-invasive, and cost-effective exam for the early detection of Coronary Artery Disease (CAD).

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Devices, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware + Subscription, Usage-Based SaaS, Government Contracts

AI Layer

Application

Keywords

coronary artery disease detectionCAD detectionnon-invasive diagnosticspoint-of-care diagnosticsdiagnostic AIPOCTmedical devicecardiac diagnosticsCAD risk assessmentearly disease detectionprimary care diagnosticsbiosignal analysisclinical decision supportECG analysisMedTechpreventive cardiology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AccuLine Comparables

Compare AccuLine with similar companies based on industry and business-model similarity.

AccuLine comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Powerful Medical
71%
Pulxion Medical Technology
68%
HeartSciences Inc.
68%

AccuLine Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 14, 2024
Pre SeedJul 6, 2022

Key People

Founding team and executive leadership

Moshe Barel

CEO & Co-Founder

Founding Team

AccuLine Investors

Notable investors and investment history

AccuLine investors
InvestorRounds
Israel Innovation AuthoritySeed
eHealth VenturesSeed, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 8, 2025

    Monthly visitors increased 493% MoM to 10.4K.

  • May 6, 2025

    Grew 27% QoQ from 11 to 14 employees.

AccuLine Filings

Explore SEC and related filing metadata, where available.

AccuLine filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AccuLine's valuation, stock price, and market status.

Is AccuLine a public or private company?

AccuLine is a private company.

What is the current stock price of AccuLine?

AccuLine is a private company with no public stock price. No recent secondary market data is available.

How much is AccuLine worth (valuation)?

Valuation information for AccuLine is not publicly available.

Can I buy AccuLine stock?

AccuLine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AccuLine's last funding round?

Funding round information for AccuLine is not publicly available.

Who are the main investors in AccuLine?

Investor information for AccuLine is not publicly disclosed.

Will AccuLine IPO soon?

No public IPO plans have been announced for AccuLine.

How can I track AccuLine secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AccuLine's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIsrael
Employee Range10
Year Founded2022
Last FundingJul 14, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?